ICON PLC
A contract research organization that runs clinical trials and outsourced drug-development services for pharmaceutical, biotechnology, and medical device companies around the world. Founded in Dublin in 1990 by two doctors who started with a team of five, the name ICON is not an acronym — it was simply chosen to reflect the company's focus on clinical research. It even built a "Country-in-a-Box" service to help clients launch trials in unfamiliar markets.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Invesco Ltd. | 13G/APassive | 6.9% | 5.26M | Aug 13, 2026 |
| FMR LLC | 13G/APassive | 6.9% | 5.27M | Aug 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 6.9% | 5.27M | Aug 6, 2026 |
| Wellington Management Group LLP | 13G/APassive | 7.7% | 5.91M | May 15, 2026 |
| Wellington Group Holdings LLP | 13G/APassive | 7.7% | 5.91M | May 15, 2026 |
| Wellington Investment Advisors Holdings LLP | 13G/APassive | 7.7% | 5.91M | May 15, 2026 |
| Wellington Management Company LLP | 13G/APassive | 6.7% | 5.91M | May 15, 2026 |
| HARRIS ASSOCIATES L P | 13GPassive | 5.7% | 4.35M | May 15, 2026 |
| Harris Associates, Inc. | 13GPassive | 5.7% | 4.35M | May 15, 2026 |
| ORBIS INVESTMENT MANAGEMENT LTD | 13G/APassive | 0% | 0 | May 15, 2026 |